Mode
Text Size
Log in / Sign up
N/A N=217 Diagnostic

IMAging With Opto-acoustics to downgradE BI-RADS claSsificaTion Relative tO Other Diagnostic Methodologies (MAESTRO)

Breast Cancer

Enrolled (actual)
217
Serious AEs
0.0%
Results posted
Apr 2020
Primary outcome: Primary: OA/US Specificity (Downgrade (%) for BI-RADS 4A & 4B) of Benign Masses — 41.1 percentage of masses

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Imagio IUS (Device); Imagio OA/US (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
Seno Medical Instruments Inc.
Primary completion
Feb 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
OA/US Specificity (Downgrade (%) for BI-RADS 4A & 4B) of Benign Masses
41.1
PRIMARY
OA/US Sensitivity (Upgrade (%) for BI-RADS 4A & 4B) of Malignant Masses
95.5

Summary

Imagio breast imaging system, is an opto-acoustic (OA) imaging system designed to concurrently collect images in conjunction with diagnostic ultrasound ( co-registered OA and B-mode imaging). This medical device has CE-marking and is approved for use in Europe and other nations. This is a post-market, non-randomized multi-center surveillance study.

Eligibility Criteria

Inclusion Criteria

  • Female
  • 18 years of age or older
  • Have an undiagnosed suspicious finding which may include more than one solid or complex cystic suspicious mass, classified by CDU as BI-RADS 4a or 4b within 3 weeks of their baseline Imagio Scan

Exclusion Criteria

  • Have a condition or impediment that could interfere with the intended field of view (within one probe length or 4 cm of the mass), (i.e., breast implants within the previous 12 months, or tattoos)
  • Pregnant or lactating
  • Patient has received chemotherapy for any type of cancer within 90 days from date of screening CDU
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02364388). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search